Drug-labels.com

Mint-Fenofibrate E: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current status: Cancelled Post Market Facts
Strength:
145 mg
Active ingredient:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Patient Medication Information: uses, side effects, how to take - Mint-Fenofibrate E

What is MINT-FENOFIBRATE E used for?

MINT-FENOFIBRATE E is used in adults, including adults with type 2 diabetes, to lower cholesterol and blood fat levels.

MINT-FENOFIBRATE E is used together with ezetimibe to lower cholesterol in adults with a specific type of high cholesterol called “mixed hyperlipidemia”.

MINT-FENOFIBRATE E is to be used together with dietary and lifestyle changes.

How does MINT-FENOFIBRATE E work?

MINT-FENOFIBRATE E lowers cholesterol by reducing the amount of bad cholesterol (LDL) and fatty substances in the blood (triglycerides). It also increases the amount of good cholesterol (HDL) in the blood.

What are the ingredients in MINT-FENOFIBRATE E?

Medicinal ingredient: fenofibrate

Non-medicinal ingredients: cellulose microcrystalline, croscarmellose sodium, hypromellose, lactose monohydrate, lecithin, magnesium stearate, polyvinyl alcohol, sodium lauryl sulphate, sucrose, talc, titanium dioxide, xanthan gum.

MINT-FENOFIBRATE E comes in the following dosage forms:

Film-coated tablets: 145 mg

Do not use MINT-FENOFIBRATE E if you:

  • have serious liver or kidney problems;
  • have gallbladder problems;
  • have pancreatitis (an inflamed pancreas which causes abdominal pain);
  • are allergic (hypersensitive) to fenofibrate or similar drugs or if you are allergic to any of the ingredients in MINT-FENOFIBRATE E;
  • are allergic (hypersensitive) to peanuts, arachis oil, soya lecithin, lactose or related products due to risk of allergic reaction;

  • are pregnant, think you may be pregnant or are planning to get pregnant. If you get pregnant while taking MINT-FENOFIBRATE E, contact your healthcare professional immediately.

  • are breast-feeding or planning to breast-feed;

    39

  • have a photoallergy (skin sensitivity to sunlight or UV light) when taking a fibrate (a class of drugs used for lowering cholesterol, which includes MINT-FENOFIBRATE E and gemfibrozol) or an anti-inflammatory drug called ketoprofen;
  • are taking statins (another type of drug used to lower cholesterol) and have muscle problems or have potential risks of developing muscle problems;
  • are under 18 years of age.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MINT-FENOFIBRATE E. Talk about any health conditions or problems you may have, including if you:

  • have liver or kidney problems;
  • have pancreas problems;
  • have gallstones;
  • have thyroid problems;
  • MINT-FENOFIBRATE E contains lactose and sucrose. Talk to your healthcare professional before taking MINT-FENOFIBRATE E if you have been told that you cannot tolerate or digest some sugars.

Other warnings you should know about:

You should have regular check-ups with your healthcare professional while taking MINT-FENOFIBRATE E. Your healthcare professional will also do regular blood work to make sure you are responding well to MINT-FENOFIBRATE E and that you are not experiencing side effects. These side effects can include serious muscle problems, which can cause kidney damage or even death. The risk of muscle problems is higher in some patients. Tell your healthcare professional if you:

  • are over 70 years old;
  • have kidney or liver problems;
  • have thyroid problems;
  • or a close family member has muscle problems which run in the family;
  • drink large amounts of alcohol;
  • have a serious infection or have recently had surgery or suffered a trauma;
  • are dehydrated or suffer from excessive vomiting, diarrhea, or sweating;
  • are taking drugs called statins to lower cholesterol such as simvastatin, atorvastatin, pravastatin, rosuvastatin or fluvastatin;
  • have ever had muscle problems during treatment with fibrates such as fenofibrate, bezafibrate or gemfibrozil.

While taking MINT-FENOFIBRATE E if you experience muscle pain, tenderness or weakness, especially with a fever, contact your healthcare professional immediately.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

40

The following may interact with MINT-FENOFIBRATE E:

  • Statins (other drugs used to lower cholesterol) such as atorvastatin, pravastatin, simvastatin, etc. Taking a statin at the same time as MINT-FENOFIBRATE E may increase the risk of serious muscle problems.
  • Blood thinners, such as warfarin;
  • Cyclosporine (a drug which may be taken following an organ transplant);
  • Cholestyramine or similar drugs (used to lower cholesterol);
  • Estrogens (hormones which may be found in birth control pills or hormone replacement therapy);
  • Some drugs used to treat diabetes, such as rosiglitazone or pioglitazone.

How to take MINT-FENOFIBRATE E:

  • MINT-FENOFIBRATE E can be taken with or without food.

  • Swallow the tablet whole with a glass of water.
  • Do not crush or chew the tablet.

Usual adult dose:

  • The recommended dose of MINT-FENOFIBRATE E is one 145 mg tablet daily.
  • If you are elderly or have kidney problems the recommended dose is one 48 mg tablet daily.

Overdose:

If you think you have taken too much MINT-FENOFIBRATE E, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you forget a dose, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

What are possible side effects from using MINT-FENOFIBRATE E?

These are not all the possible side effects you may feel when taking MINT-FENOFIBRATE E. If you experience any side effects not listed here contact your health care professional.

Side effects may include:

  • Stomach pain, constipation, diarrhea, gas
  • Nausea, vomiting
  • Headache
  • Dizziness
  • Fatigue
  • Trouble sleeping
  • Low sex drive
  • Skin rashes, redness and itching, sensitivity of the skin to light
  • Hair loss

  • Weight loss

    41

  • Joint pain

MINT-FENOFIBRATE E can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help

Only if

severe

In all cases

UNCOMMON

Allergic reaction: swelling of the face, lips, tongue or throat, which may cause difficulty in breathing

✓

Blood clot in the lung: sudden chest pain

and trouble breathing

✓

Blood clot in the leg: pain, redness or

swelling in the legs

✓

Inflammation of the pancreas:

stomach pain that lasts and gets worse when you lie down, nausea, vomiting

✓

RARE

Serious muscle problems: muscle pain

or cramps, or muscle weakness, especially together with fever and generally feeling unwell

✓

Liver problems: yellowing of the skin

and whites of the eyes, dark urine

✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

42

Storage:

Store at 15oC to 30oC. Protect from light and moisture.

Keep out of reach and sight of children.

If you want more information about MINT-FENOFIBRATE E:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (www.healthcanada.gc.ca); the manufacturer’s website (www.mintpharmaceuticals.com), or by calling 1-877-398-9696.

Mississauga, Ontario L5T 1J6

Prepared on: June 15, 2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02465167

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mint-Fenofibrate E

Rx or OTC
Prescription (Rx)?
DIN 02465167
Schedule(s) PRESCRIPTION
Active ingredient(s) Fenofibrate 145 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AB Fibrates, lipid modifying drugs, plain
          1. C10AB05 Fenofibrate
Company MINT PHARMACEUTICALS INC
Current status Cancelled Post Market
Current status date April 28, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.